Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Receives CE Mark for CupPrint

NEW YORK (GenomeWeb News) - Agendia's CupPrint microarray service has acquired Medical Device registration at the Dutch Healthcare Inspectorate, the company said today.

 
Agendia received CE registration for MammaPrint in 2005.
 
CupPrint is a test for cancer of unknown primary patients.
 
"With the CE registration of both its products and the ISO 17025 accreditation of its laboratory services, Agendia ... [can] market its products and ... provide a legal basis for its use in clinical practice," Laura van 't Veer, COO of Agendia, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.